Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2014
08/21/2014US20140234357 H5 proteins of h5n1 influenza virus for use as a medicament
08/21/2014US20140234356 Influenza antigen delivery vectors and constructs
08/21/2014US20140234353 Methods of obtaining antigen-specific t cell populations
08/21/2014US20140234351 Cancer vaccines and vaccination methods
08/21/2014US20140234350 Ovarian cancer vaccines and vaccination methods
08/21/2014US20140234341 Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof
08/21/2014US20140234329 Antibodies against the ectodomain of erbb3 and uses thereof
08/21/2014US20140234324 Methods for treating a tumor using an antibody that specifically binds grp94
08/21/2014US20140234322 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
08/21/2014US20140234318 Tumor specific oligosaccharide epitopes and use thereof
08/21/2014US20140234317 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
08/21/2014US20140234314 Antibodies against epidermal growth factor receptor (egfr) and uses thereof
08/21/2014US20140234310 Compositions and methods for treatment of bacterial and mycobacterial infections
08/21/2014US20140234308 Treatment of breast cancer with companion diagnostic
08/21/2014US20140234305 Methods of treatment using bevacizumab
08/21/2014US20140234303 Treatment of neurological conditions
08/21/2014US20140234300 Method of modulating the activity of functional immune molecules
08/21/2014US20140234299 Therapies for chronic renal failure using one or more integrin antagonists
08/21/2014US20140234296 Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments
08/21/2014US20140234293 Combination Therapy Using Immunoglobulin and C1-Inhibitor
08/21/2014US20140234253 Combination Treatments For Hepatitis C
08/21/2014US20140234222 Use of tnf alpha inhibitor for treatment of erosive polyarthritis
08/21/2014US20140234213 Rationally-Designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies
08/21/2014US20140234209 Chimeric and humanized anti-histone antibodies
08/21/2014US20140234208 Dual variable domain immunoglobulins and uses thereof
08/20/2014EP2766731A1 Allergens from insects
08/20/2014EP2766395A1 Antibody polypeptides that antagonize cd40l
08/20/2014EP2766393A1 ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
08/20/2014EP2766386A1 Self-assembling peptide nanoparticles as vaccines against infection with norovirus
08/20/2014EP2766385A2 Cmv antigens and uses thereof
08/20/2014EP2766093A1 Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability
08/20/2014EP2766045A2 Treatment of breast cancer with companion diagnostic
08/20/2014EP2766044A1 Treatment of ocular disease
08/20/2014EP2766043A1 Methods for treating vascular leak syndrome and cancer
08/20/2014EP2766042A1 ANTIBODIES TO CD1d
08/20/2014EP2766041A1 Combinatorial compositions and methods of treating hemoglobinopathies
08/20/2014EP2766040A2 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
08/20/2014EP2766039A1 Compositions for the treatment of rheumatoid arthritis and methods of using same
08/20/2014EP2766038A1 Cchfv vaccine
08/20/2014EP2766037A1 An hiv-1 gp120 mini v3 loop and uses thereof
08/20/2014EP2766035A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
08/20/2014EP2766033A2 Antibodies and methods for wnt pathway-related diseases
08/20/2014EP2766030A1 Engineered outer domain (eod) of hv gp120 and mutants thereof
08/20/2014EP2766016A1 Improved sperm function/activity
08/20/2014EP2766000A2 Scd1 antagonists for treating cancer
08/19/2014US8809510 Method for purification of complement factor H
08/19/2014US8809506 Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
08/19/2014US8809503 Optimized Fc variants and methods for their generation
08/19/2014US8809502 Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
08/19/2014US8809495 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
08/19/2014US8809494 Method and compositions for prevention and treatment of malaria infections
08/19/2014US8809297 Anticancer composition
08/19/2014US8809290 Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells
08/19/2014US8809051 Transgenic mammals having human Ig loci including plural VH and Vκ regions and antibodies produced therefrom
08/19/2014US8809047 Herpes simplex virus vaccines
08/19/2014US8808998 Diagnostic method for atherosclerosis
08/19/2014US8808712 Malaria vaccine
08/19/2014US8808711 Meningococcal outer membrane vesicles
08/19/2014US8808710 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
08/19/2014US8808709 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
08/19/2014US8808708 Multivalent pneumococcal polysaccharide-protein conjugate composition
08/19/2014US8808707 Pneumococcal dosing regimen
08/19/2014US8808704 Non-coiled protective regions of pneumococcal surface proteins PspA and PspC
08/19/2014US8808703 Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc
08/19/2014US8808701 Methods of inhibiting the interaction of C5aR with C5a with anti-C5aR antibodies
08/19/2014US8808700 Use of TNF alpha inhibitor for treatment of erosive polyarthritis
08/19/2014US8808699 Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
08/19/2014US8808698 Methods for inhibition of lymphangiogenesis and tumor metastasis
08/19/2014US8808696 Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
08/19/2014US8808695 Monoclonal antibodies to progastrin
08/19/2014US8808694 Therapeutic peptidomimetic macrocycles
08/19/2014US8808693 Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses
08/19/2014US8808692 Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
08/19/2014US8808691 Method for treating tumors and their metastases
08/19/2014US8808686 Adjuvant-sparing multi-dose influenza vaccination regimen
08/19/2014US8808684 Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
08/19/2014US8808683 Genetically modified bacterium of the species Listeria monocytogenes
08/19/2014US8808667 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
08/19/2014US8808664 Lipidated glycoprotein particles and methods of use
08/19/2014CA2690668C Vaccines containing canine parvovirus genetic variants
08/19/2014CA2676699C An hbv vaccine and a process of preparing the same
08/19/2014CA2651285C Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
08/19/2014CA2614972C Human anti-b7rp1 neutralizing antibodies
08/19/2014CA2601676C Combination vaccines with whole cell pertussis antigen
08/19/2014CA2595939C Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists
08/19/2014CA2490659C Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
08/19/2014CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use
08/19/2014CA2426200C Inhibition or reversal of skin aging by actin-sequestering peptides
08/14/2014WO2014124446A1 Group a streptococcal m-related proteins and methods of use
08/14/2014WO2014124423A1 Combination vaccine for respiratory syncytial virus and influenza
08/14/2014WO2014124238A1 Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
08/14/2014WO2014124227A1 Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
08/14/2014WO2014124156A1 B cell lineage based immunogen design with humanized animals
08/14/2014WO2014124144A1 Methods for enhancing an immune response to an antigen
08/14/2014WO2014124134A1 Methods for expansion or depletion of t-regulatory cells
08/14/2014WO2014124047A1 Antimicrobial peptides derived from hepatitis b virus core protein arginine-rich domain
08/14/2014WO2014123696A1 Compositions for selective reduction of circulating bioactive soluble tnf and methods for treating tnf-mediated disease
08/14/2014WO2014123580A1 Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereof
08/14/2014WO2014123476A1 Improved treatment for adenoid cystic carcinoma
08/14/2014WO2014122660A1 Cd14 inhibitors as an effective treatment for hcv infection
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 1823